Article
Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.
Nature reviews. Cancer - 1 Jul 2015
Kashi Venkatesh P, Hatley Mark E, Galindo Rene L
Abstract excerpt
Rhabdomyosarcoma (RMS) is a mesenchymal malignancy composed of neoplastic primitive precursor cells that exhibit histological features of myogenic differentiation. Despite intensive conventional multimodal therapy, patients with high-risk RMS typically suffer from aggressive disease. The lack of directed therapies against RMS emphasizes the need to further uncover the molecular underpinnings of the disease. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
